BriaCell Therapeutics Corp. (TSX:BCT)
3.990
+0.190 (5.00%)
Jun 15, 2026, 11:50 AM EST
BriaCell Therapeutics Market Cap
BriaCell Therapeutics has a market cap or net worth of CAD 33.06 million as of June 15, 2026. Its market cap has increased by 23.42% in one year.
Market Cap
33.06M
Enterprise Value
1.13M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
3.99
Market Cap Chart
Since December 3, 2014, BriaCell Therapeutics's market cap has increased from 24.42M to 33.06M, an increase of 35.40%. That is a compound annual growth rate of 2.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2026 | 33.06M | 79.06% |
| Dec 31, 2025 | 18.46M | -48.44% |
| Dec 31, 2024 | 35.81M | -71.28% |
| Dec 29, 2023 | 124.66M | 36.15% |
| Dec 30, 2022 | 91.56M | -44.85% |
| Dec 31, 2021 | 166.03M | 3,496.79% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sernova Biotherapeutics | 54.67M |
| NurExone Biologic | 47.86M |
| MedMira | 45.61M |
| Microbix Biosystems | 41.33M |
| Defence Therapeutics | 40.93M |
| Medicenna Therapeutics | 38.77M |
| Resverlogix | 34.38M |
| Quantum BioPharma | 34.30M |